Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TSHZ1 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-08 |
mRNA | RARS | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-08 |
mRNA | LUC7L | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
mRNA | CDK19 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
mRNA | ZNF417 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-08 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | RBBP4 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | MTURN | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |